These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 16924260)

  • 1. Molecular biology of amyotrophic lateral sclerosis: insights from genetics.
    Pasinelli P; Brown RH
    Nat Rev Neurosci; 2006 Sep; 7(9):710-23. PubMed ID: 16924260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of rapid disease progression in ALS.
    Yamanaka K; Cleveland DW
    Neurology; 2005 Dec; 65(12):1859-60. PubMed ID: 16380607
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid disease progression correlates with instability of mutant SOD1 in familial ALS.
    Sato T; Nakanishi T; Yamamoto Y; Andersen PM; Ogawa Y; Fukada K; Zhou Z; Aoike F; Sugai F; Nagano S; Hirata S; Ogawa M; Nakano R; Ohi T; Kato T; Nakagawa M; Hamasaki T; Shimizu A; Sakoda S
    Neurology; 2005 Dec; 65(12):1954-7. PubMed ID: 16291929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rodent Models of Amyotrophic Lateral Sclerosis.
    Philips T; Rothstein JD
    Curr Protoc Pharmacol; 2015 Jun; 69():5.67.1-5.67.21. PubMed ID: 26344214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas(t) balls and Lou Gehrig disease. A clue to selective vulnerability of motor neurons?
    Xiong ZQ; McNamara JO
    Neuron; 2002 Sep; 35(6):1011-3. PubMed ID: 12354390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?
    Bacman SR; Bradley WG; Moraes CT
    Mol Neurobiol; 2006 Apr; 33(2):113-31. PubMed ID: 16603792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
    Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
    Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdk5 sinks into ALS.
    Patzke H; Tsai LH
    Trends Neurosci; 2002 Jan; 25(1):8-10. PubMed ID: 11801324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic lateral sclerosis: pathogenesis.
    Brown RH; Robberecht W
    Semin Neurol; 2001 Jun; 21(2):131-9. PubMed ID: 11442322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superoxide dismutase: the cause of all amyotrophic lateral sclerosis?
    Matias-Guiu J; Galan L; Garcia-Ramos R; Barcia JA
    Ann Neurol; 2008 Sep; 64(3):356-7; author reply 358. PubMed ID: 18350588
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Curr Mol Med; 2009 Apr; 9(3):255-72. PubMed ID: 19355908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
    Zimmerman MC; Oberley LW; Flanagan SW
    J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
    Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
    Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.
    Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH
    Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
    Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories.
    Beghi E; Mennini T;
    Neurol Sci; 2004 Jun; 25 Suppl 2():S41-60. PubMed ID: 15197603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
    Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
    Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
    Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
    Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysequilibrium between caspases and their inhibitors in a mouse model for amyotrophic lateral sclerosis.
    Tokuda E; Ono S; Ishige K; Watanabe S; Okawa E; Ito Y; Suzuki T
    Brain Res; 2007 May; 1148():234-42. PubMed ID: 17397813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetics of amyotrophic lateral sclerosis.
    Kuźma-Kozakiewicz M; Kwieciński H
    Neurol Neurochir Pol; 2009; 43(6):538-49. PubMed ID: 20054757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.